A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
Pfizer
Pfizer
Eli Lilly and Company
National Cancer Institute (NCI)
University of Illinois at Chicago
Yale University
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Novartis
Duke University
Tufts Medical Center
National Institutes of Health Clinical Center (CC)